Cargando…
Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse
PURPOSE: To evaluate the characteristics and frequency of remission in pediatric patients with Graves’ disease (GD) treated with antithyroid drug (ATD) and to identify factors that may be associated with relapse. METHODS: Medical records of patients younger than 19 years who presented to the Departm...
Autores principales: | Wong, Tsz Wai Catherine, Wong, Man Yee Shirley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Pediatric Endocrinology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816462/ https://www.ncbi.nlm.nih.gov/pubmed/36567464 http://dx.doi.org/10.6065/apem.2244038.019 |
Ejemplares similares
-
Commentary on “Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse”
por: Kim, Ji Hyun
Publicado: (2022) -
Clinical Features and Remission Rate of Pediatric Graves’ Hyperthyroidism Treated With Antithyroid Drug
por: You, Kyusang, et al.
Publicado: (2021) -
Predictors of Initial and Sustained Remission in Patients Treated with Antithyroid Drugs for Graves' Hyperthyroidism: The RISG Study
por: Karmisholt, J., et al.
Publicado: (2019) -
Features of partial remission in children with type 1 diabetes using the insulin dose-adjusted A1c definition and risk factors associated with nonremission
por: Wong, Tsz Wai Catherine, et al.
Publicado: (2021) -
Technetium uptake predicts remission and relapse in Grave's disease patients on antithyroid drugs for at least 1 year in South Indian subjects
por: Singhal, Neha, et al.
Publicado: (2016)